Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Patent
1989-06-05
1990-11-13
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
424647, 424648, A61K 3326
Patent
active
049700790
ABSTRACT:
Oxy-iron compounds are useful for the treatment and prevention of hyperphosphatemia. Such compounds, particularly those exhibiting high surface area, can be administered orally to bind and inhibit absorption of dietary phosphate, or such compounds can be contacted with the dialysate in a hemodialysis unit to enhance reduction of serum phosphate of patients undergoing hemodialysis.
REFERENCES:
patent: 4181718 (1980-01-01), Mason et al.
patent: 4474853 (1980-10-01), Watanabe
patent: 4581141 (1983-05-01), Ash
patent: 4668400 (1987-05-01), Veech
patent: 4870105 (1989-10-01), Fordtran
Mann et al., Formation of Iron Oxides in Unilamellar Vessicles. J. Colloidal Interface Sci. 122(2) 326-335 (1988).
Coburn, Jack W., M.D. and Isidro B. Salusky, M.D., "Control of Serum Phosphorus in Uremia", The New England Journal of Medicine, Apr. 27, 1989, pp. 1140-1142.
Stucki, J. W., B. A. Goodman and U. Schwertmann, "Iron in Soils and Clay Minerals", Published in cooperation with NATO Scientific Affairs Division.
Hem Stanley L.
White Joseph L.
Hollinden Gary E.
Purdue Research Foundation
Robinson Douglas W.
LandOfFree
Method and composition of oxy-iron compounds for treatment of hy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition of oxy-iron compounds for treatment of hy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition of oxy-iron compounds for treatment of hy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-775987